ArticleBMC musculoskeletal disorders2025
Identification and validation of ferroptosis-related key hub genes linking hypoxia and osteoporosis.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundOsteoporosis (OP) is a prevalent progressive metabolic bone disease in the middle-aged and elderly population. Previous research has indicated that physiological or pathological hypoxia may disrupt bone metabolism, ultimately contributing to OP development. However, the specific pathophysiological mechanisms remain unknown. Ferroptosis is a novel iron-dependent non-apoptotic cell death pathway. The objective of this investigation was to use bioinformatics analysis to identify key hub genes related to ferroptosis that may be linked to hypoxia and osteoporosis. Subsequently, we utilized experimental methods to validate these findings.
methodsDifferentially expressed genes (DEGs) in bone marrow mesenchymal stem cells (BMSCs) from primary osteoporosis patients and hypoxia-treated BMSCs were screened from the Gene Expression Omnibus (GEO) database. These DEGs were then intersected with the ferroptosis dataset (FerrDb), resulting in FerrDEGs. The potential functional roles of FerrDEGs were investigated through gene ontology (GO) and pathway enrichment analysis (e.g., KEGG, WikiPathways and Reactome). The STRING database was used to analyze protein-protein interaction networks, pinpointing hub genes within FerrDEGs. To further assess the predictive value of these hub genes, we conducted ROC analysis using the data from GSE230665 to identify key hub genes. Subsequently, NetworkAnalyst was employed to establish networks between target microRNAs(miRNAs) and key hub genes. Finally, we validated the key hub genes and miRNAs in an OVX rat model for further confirmation.
resultsA total of 50 FerrDEGs were identified in the overlap of hypoxia, OP, and ferroptosis pathways. These FerrDEGs were primarily associated with biological processes related to cellular response to chemical stress and oxidative stress. Pathway enrichment analysis revealed that these FerrDEGs played significant roles in processes such as viral carcinogenesis and epstein-barr virus infection. Multiple algorithms (CytoHubba, CytoNCA and Analyze Network) were employed to identify eight hub genes within FerrDEGs, including TP53, JUN, SQSTM1, STAT3, CDKN1A, CAV1, CD44 and TGFBR1. Five key hub genes (JUN, SQSTM1, STAT3, CD44 and TGFBR1) were further screened by ROC analysis. Subsequently, hsa-miR-20a-5p was identified as a potential key microRNA through the construction of the miRNA-gene network. The five key hub genes and rno-miR-20a-5p were further validated in the OVX rat model.
conclusionIn summary, we first screened ferroptosis-related key hub genes linking hypoxia and osteoporosis. The findings suggest that JUN, SQSTM1, STAT3 , CD44 and TGFBR1 are significantly associated with OP and hypoxia, potentially serving as biomarkers for diseases linked to ferroptosis. Additionally, hsa-miR-20a-5p was identified as a crucial upstream regulator likely involved in the regulation of these genes simultaneously.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.